A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy
Clinical trial NCT03405714 · COMPLETED
Trial details
- NCT number
- NCT03405714
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2020-11-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.